PFSA NorthView Acquisition Corp

OTC N/A


$ 0.29 $ 0.01 (2.1 %)    

Monday, 27-Oct-2025 17:45:24 EDT
QQQ $ 628.93 $ 10.99 (1.78 %)
DIA $ 475.40 $ 3.14 (0.66 %)
SPY $ 685.52 $ 7.99 (1.18 %)
TLT $ 91.88 $ 0.31 (0.34 %)
GLD $ 367.78 $ -10.51 (-2.78 %)
$ 0.2961
$ 0.29
$ 0.28 x 15
$ 0.31 x 10,100
$ 0.28 - $ 0.30
$ 0.26 - $ 12.76
1,909,739
na
nm
nm
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 06-13-2025 03-31-2025 10-Q
3 03-29-2025 12-31-2024 10-K
4 12-17-2024 09-30-2024 10-Q
5 11-15-2024 06-30-2024 10-Q
6 10-09-2024 03-31-2024 10-Q
7 02-23-2024 12-31-2023 10-K
8 11-20-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-17-2023 03-31-2023 10-Q
11 03-06-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-17-2022 12-31-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

- Reuters

Core News & Articles

BERKELEY, Calif, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a ...

Core News & Articles

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001859807/000121390025097860/ea0258580-s1_profusa.htm

Core News & Articles

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering ...

Core News & Articles

Company expects early 2026 rollout in EEA; physician portal combines Lumee™ oxygen monitoring with NVIDIA NeMo to deliver AI-dr...

Core News & Articles

Led by Prof. Dr. Marianne Brodmann, PI of clinical studies for the Lumee™ Oxygen CE Mark, collaboration includes practice adopt...

Core News & Articles

Profusa, Inc. ("Profusa" or the "Company") (NASDAQ:PFSA), a commercial stage digital health company pioneering ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION